Allegro Diagnostics Obtains $5,400,000 Series A Funding

  • Feed Type
  • Date
    7/7/2011
  • Company Name
    Allegro Diagnostics
  • Mailing Address
    6 Clock Tower Place Maynard, MA 01754
  • Company Description
    Allegro Diagnostics is a leader in the field of gene expression molecular diagnostic testing for lung cancer and other diseases.
  • Website
    http://www.allegrodx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,400,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will support the commercialization of Allegro’s lead genomic test, BronchoGen, in 2012.
  • M&A Terms
  • Venture Investor
    Kodiak Venture Partners
  • Venture Investor
    Catalyst Health Ventures

By posting a comment, you agree to our terms and conditions.